Clincosm LogoSign in Get a demo

Comparison Of Doxycycline And Common Salt For Treatment Of Umbilical Granuloma: A Randomised Control Trial

Sponsor
Shaheed Zulfiqar Ali Bhutto Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT05545462
Collaborator
(none)
196
Enrollment
1
Location
2
Arms
12
Actual Duration (Months)
16.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

it is the study for the disease called umbilical granuloma to look for the better treatment option which can be performed by healthcare physicians and local nurses and even parents

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

umbilical granuloma is a condition for which multiple treatments are available those including interventional and non interventional, most of the treatments are performed by the health care physician like application of silver nitrate cryotherapy, electrocautery, double ligation.

the main goal of this study is to prefer those method or drugs which could be safely used by the nurses the health care personal and even by parents at home with fewer side effects

Study Design

Study Type:
Interventional
Actual Enrollment :
196 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Health Services Research
Official Title:
Comparison Of Doxycycline And Common Salt (TableCooking) For Treatment Of Umbilical Granuloma In Children: A Randomised Control Trial
Actual Study Start Date :
Oct 1, 2020
Actual Primary Completion Date :
Sep 30, 2021
Actual Study Completion Date :
Sep 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: COMPARISON OF DOXYCYCLINE AND COMMON SALT FOR TREATMENT OF UMBILICAL GRANULOMA IN CHILDREN

to study the comparison of doxycycline and common salt for the treatment of umbilical granuloma to check which is more effective safe timesaving and can be performed by even parents it showed that common salt is more effective than doxycycline

Drug: Doxycyclin
THE USE OF DOXYCYCLIN POWDER IN THE TREATMENT OF UMBILICAL GRANULOMA
Other Names:
  • COMMON SALT

    		•
    Experimental: COMPARISON BETWEEN COMMON SALT AND SOXYCYLIN FOR TREATMENT OF UMBILICAL GRANULOMA

    to study the comparison of doxycycline and common salt for the treatment of umbilical granuloma to check which is more effective safe timesaving and can be performed by even parents it showed that common salt is more effective than doxycycline

    Other: COMMON SALT
    THE USE OF COMMON SALT IN TREATMENT OF UMBILICAL GRANULOMA

    Outcome Measures

    Primary Outcome Measures

    1. Comparison Of Doxycycline And Common Salt (TableCooking) For Treatment Of Umbilical Granuloma In Children: A Randomised Control Trial [1 year]

      for the treatment of Umbilical Granuloma multiple treatment options are available. and we have studied about the two methods the common salt any doxycycline The use of common salt to treat umbilical granuloma is a simple, highly effective, and inexpensive with minimum complications or relapse as compared to doxycycline. Treatment can be performed by physicians, nurses, primary health-care staff in remote areas, and even by parents.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Month to 1 Year
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Inclusion criteria:

    1. Neonates and infants (age<1yr)

    2. Both genders

    3. Confirmed by ultrasonography and sinography (if applicable)

    Exclusion Criteria:
      1. If any treatment is already given 2. Patient lost in follow up 3. Refusal

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Pakistan institute of medical Sciences/ Shaheed Zulfiqar Ali Bhutto Medical University Islamabad Pakistan

    Sponsors and Collaborators

    • Shaheed Zulfiqar Ali Bhutto Medical University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dr.M. Awais, Dr. Muhammad Awais, Shaheed Zulfiqar Ali Bhutto Medical University
    ClinicalTrials.gov Identifier:
    NCT05545462
    Other Study ID Numbers:
    • 356/SZABMU/MS-2017
    First Posted:
    Sep 19, 2022
    Last Update Posted:
    Sep 19, 2022
    Last Verified:
    Sep 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Additional relevant MeSH terms:
    Granuloma
    Doxycycline

    Study Results

    No Results Posted as of Sep 19, 2022